forward looking statements

Search documents
Hippo (HIPO) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:00
Hippo (HIPO) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Good afternoon. Thank you for attending the Hippo First Quarter twenty twenty five Holdings Call. My name is Cameron, and I'll be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. And I would now like to pass the conference over to your host, Mark Olson, Director of Communications. You may proceed. Speaker1 Thank you, operator. Good aftern ...
Greystone Housing Impact Investors LP(GHI) - 2025 Q1 - Earnings Call Transcript
2025-05-07 21:32
Greystone Housing Impact Investors LP (GHI) Q1 2025 Earnings Call May 07, 2025 04:30 PM ET Company Participants Jesse Coury - Chief Financial OfficerKenneth Rogozinski - Chief Executive OfficerMatthew Erdner - DirectorChris Muller - Director - Equity Research Conference Call Participants Jason Stewart - Director & Equity Research Analyst Operator and welcome to First Quarter twenty twenty five Earnings Call for Greystone Housing Impact Investors. At this time, all participants are in a listen only mode. A q ...
Mammoth Energy Services(TUSK) - 2025 Q1 - Earnings Call Transcript
2025-05-07 16:02
Mammoth Energy Services (TUSK) Q1 2025 Earnings Call May 07, 2025 11:00 AM ET Company Participants Zach Vaughan - Vice PresidentPhil Lancaster - CEO & DirectorMark Layton - CFOJoshua Jayne - Managing Director Operator a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Zach Phong. Thank you. You may begin. Zach Vaughan Thank you, operator, and good morning, everyone. We appreciate you joining us for the Mammoth Energy conference call to review twenty twenty five firs ...
UFG(UFCS) - 2025 Q1 - Earnings Call Transcript
2025-05-07 16:02
United Fire Group (UFCS) Q1 2025 Earnings Call May 07, 2025 11:00 AM ET Company Participants Tim Borst - Head of Corporate Development, Capital Management, and Investor RelationsKevin Leidwinger - President & CEOJulie Stephenson - EVP & Chief Operating OfficerEric Martin - EVP & CFOMatthew Erdner - Director Operator day, and welcome to the United Fire Group Insurance twenty twenty five First Quarter Conference Call. All participants will be in listen only mode. After today's presentation, there will be an o ...
UWM Holdings Corporation (UWMC) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-06 15:57
UWM Holdings Corporation (NYSE:UWMC) Q1 2025 Earnings Conference Call May 6, 2025 10:00 AM ET Company Participants Blake Kolo - Chief Business Officer & Head, IR Mat Ishbia - Chairman & CEO Rami Hasani - CFO Conference Call Participants Eric Hagen - BTIG Bose George - KBW Jeff Adelson - Morgan Stanley Mikhail Goberman - Citizens Doug Harter - UBS Operator Good morning, my name is Abby and I'll be your conference operator today. At this time, I would like to welcome everyone to the UWM Holdings Corporation F ...
CorMedix(CRMD) - 2025 Q1 - Earnings Call Transcript
2025-05-06 13:32
CorMedix (CRMD) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Company Participants Dan Ferry - Managing DirectorJoe Todisco - Chief Executive OfficerMatt David - Executive VP & CFOLes Sulewski - VP - Biotech Equity ResearchLiz Hurlburt - EVP, Chief Clinical Strategy and Operations Officer Conference Call Participants Gregory Renza - Senior Biotechnology AnalystRoanna Ruiz - Senior Managing Director, Biotechnology AnalystSerge Belanger - Senior Analyst Operator Good day, and welcome to the CorMedix Inc. Fir ...
iRadimed(IRMD) - 2025 Q1 - Earnings Call Transcript
2025-05-05 13:00
Financial Data and Key Metrics Changes - For Q1 2025, the company achieved revenue of $19.5 million, an 11% increase from $17.6 million in Q1 2024 [4][11] - Gross profit margin was reported at 76.1%, consistent with Q1 2024 [12] - GAAP diluted earnings per share increased by 16% to $0.37 from $0.32 in Q1 2024 [13] - Non-GAAP adjusted net income was $5.3 million or $0.42 per diluted share, up 17% from $4.6 million or $0.36 per diluted share in Q1 2024 [14] Business Line Data and Key Metrics Changes - Revenue from IV infusion pump systems grew 16% to $6 million, while disposable revenue increased 23% to $4.9 million [11][12] - Patient vital signs monitoring systems revenue remained steady at $6.5 million [12] - Domestic sales accounted for 82% of total revenue, up from 76% in Q1 2024, with domestic revenue increasing 19% to $16 million [12] Market Data and Key Metrics Changes - International sales declined 15% to $3.5 million [12] - Device revenue increased 9% to $13 million, driven by pump revenue and FMD systems [12] Company Strategy and Development Direction - The company is focused on increasing monitoring sales in 2025, anticipating a decline in pump revenues later in the year [21] - The new 3,870 MRIV pump is expected to be a revenue driver in 2026, with clearance anticipated in mid-2025 [9][10] - The company is nearing completion of a new facility, with full operations expected by July 2025 [10] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about the impact of tariffs, noting that only 3% of revenue is connected to high tariff sources [6][7] - The FDA's responsiveness has been positive, with ongoing interactions indicating progress towards device clearance [25][27] - The company expects Q2 2025 revenue guidance of $19.7 million to $19.9 million, reiterating full-year revenue guidance of $78 million to $82 million [10] Other Important Information - Operating expenses were $9.4 million, or 48% of revenue, down from 49% in Q1 2024 [12] - Cash flow from operations was $4.3 million, up 10% from $3.9 million in Q1 2024 [14] Q&A Session Summary Question: Any anomalies in disposable revenue growth? - Management indicated that some backlog was worked down in Q1, contributing to the growth, but expects future growth to align with capital growth [17][18] Question: Confidence in monitoring sales recovery? - Management emphasized efforts to boost monitoring sales through adjusted compensation structures, with strong bookings already seen in Q2 [20][22] Question: Status of FDA interactions and clearance timeline? - Management noted ongoing interactive questions from the FDA, suggesting a positive sign, with expectations for clarity in the next three to four weeks [24][27]
Barfresh(BRFH) - 2025 Q1 - Earnings Call Transcript
2025-05-01 21:32
Barfresh Food Group (BRFH) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Company Participants Riccardo Delle Coste - Founder, Chairman, President & CEOLisa Roger - Chief Financial OfficerAnthony Vendetti - Executive Managing Director Conference Call Participants None - Analyst Operator Good afternoon, everyone, and thank you for participating on today's first quarter twenty twenty five corporate update call for Barfresh Food Group. Joining us today is Barfresh Food Group's Founder and CEO, Ricardo Dele Cos ...
Landmark Bancorp(LARK) - 2025 Q1 - Earnings Call Transcript
2025-05-01 15:32
Landmark Bancorp (LARK) Q1 2025 Earnings Call May 01, 2025 10:30 AM ET Company Participants Abby Wendel - President, CEO & DirectorMark Herpich - VP, Secretary, CFO & TreasurerRaymond McLanahan - CCO Operator Hello, everyone. And welcome to the Landmark Bancorp Inc q one earnings call. My name is Nadia, and I'll be coordinating the call today. If you would like to ask a question, please press star, followed by one on your telephone keypad. I will now hand over to your host, Abby Wendell, president and chief ...
Landmark Bancorp(LARK) - 2025 Q1 - Earnings Call Transcript
2025-05-01 14:30
Financial Data and Key Metrics Changes - Net income for Q1 2025 totaled $4,700,000, a significant increase from $2,800,000 in the same period last year, representing a growth of 68% [4][8] - Diluted earnings per share rose to $0.81, marking a 69% increase year-over-year [4] - Return on average assets was 1.21% and return on average equity was 13.71% [4] - Efficiency ratio improved to 64.1% in Q1 2025 [4] Business Line Data and Key Metrics Changes - Total gross loans increased by $22,600,000 or 8.7% on an annualized basis, reaching nearly $1,100,000,000 [5][12] - Loan growth was primarily driven by commercial real estate and construction loans, which increased by $14,400,000 and $3,300,000 respectively [13][17] - Non-interest income totaled $3,400,000, a slight decline compared to the previous quarter [11] Market Data and Key Metrics Changes - Deposits totaled $1,300,000,000 at the end of Q1 2025, with an increase of $7,100,000 during the quarter [13] - Interest checking and money market deposits declined by $23,500,000, while non-interest checking increased by $16,900,000 [14] Company Strategy and Development Direction - The company remains focused on serving business owners across Kansas, emphasizing relationship banking [5] - There is a commitment to maintaining solid credit quality amid economic uncertainties [21] - The company aims to strengthen existing customer relationships and grow lending and fee businesses across all markets [21] Management Comments on Operating Environment and Future Outlook - Management noted a general level of uncertainty among customers but expressed confidence that uncertainties will resolve over time [20] - The economic landscape in Kansas is described as healthy, with an unemployment rate of 3.8% [19] - The company is well-positioned for future growth due to its operational success and high-quality banking products [21] Other Important Information - The Board of Directors declared a cash dividend of $0.21 per share, marking the 95th consecutive quarterly cash dividend since the company's formation [6] - The allowance for credit losses stood at $12,800,000, representing 1.19% of gross loans [11][19] Q&A Session Summary Question: No questions were asked during the Q&A session - There were no questions from participants during the call, leading to a prompt conclusion of the session [24]